David R. Langley
0000-0002-0820-3190
Publication & Citation Trends
Publications
0 total
Accurate Physics-Based Prediction of Binding Affinities of RNA- and DNA-Targeting Ligands
Cited by 5
Semantic Scholar
Synthetic studies toward a simplified eleuthoside core
Cited by 0
Semantic Scholar
Mutagenic Activation of Glutathione Peroxidase-4: Approaches toward Rational Design of Allosteric Drugs OA
Cited by 4
Semantic Scholar
PROTAC targeted protein degraders: the past is prologue OA
Cited by 2,250
Semantic Scholar
DNA-Model-Based Design and Execution of Some Fused Benzodiazepine Hybrid Payloads for Antibody-Drug Conjugate Modality. OA
Cited by 4
Semantic Scholar
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.
Cited by 8
Semantic Scholar
Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrase.
Cited by 6
Semantic Scholar
Design, Synthesis, and Structure-Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody-Drug Conjugates.
Cited by 12
Semantic Scholar
Research Topics
HIV/AIDS drug development and treatment
(27)
HIV Research and Treatment
(19)
Protein Structure and Dynamics
(12)
Protein Degradation and Inhibitors
(12)
Cancer therapeutics and mechanisms
(11)
Affiliations
Wesleyan University
Hershey (United States)
University of Hertfordshire
Bristol-Myers Squibb (Germany)
GlaxoSmithKline (United Kingdom)